Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diphtheria01:28

Diphtheria

16
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
16
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

849
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
849
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.4K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

5
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
5
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

4
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
4

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amebiasis as a neglected tropical disease: Current knowledge gaps and future directions.

PLoS neglected tropical diseases·2026
Same author

Multi-strain Clostridioides difficile infection: Increased detection and clinical implications.

The Journal of infection·2026
Same author

Isolating C. difficile from Animal Samples.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

Treating Initial and Recurrent <i>C. difficile</i>: A Retrospective Analysis of 100 Referred Patients.

Microorganisms·2026
Same author

Pathogenicity of <i>Brucella</i> sp. ST27 <i>Kogia sima</i> Isolates in Murine and Cell Models.

Tropical medicine and infectious disease·2026
Same author

CSPG4 Mediates Inflammatory, Cell Death, and Senescence Responses in Enteric Glia Exposed to Clostridioides difficile Toxins.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same journal

Muc16 contributes to protection against invasive pneumococcal infection originating from nasal colonization.

Microbiology spectrum·2026
Same journal

Tail-specific protease (Tsp)-mediated envelope remodeling and beta-lactam tolerance in <i>Escherichia coli</i>.

Microbiology spectrum·2026
Same journal

Comparative evaluation of EUCAST RAST and QuickMIC for rapid antimicrobial susceptibility testing of carbapenem-resistant organisms directly from positive blood cultures.

Microbiology spectrum·2026
Same journal

Systematic discovery of novel phosphoinositide-binding effectors in <i>Legionella</i> reveals conserved É‘-helical folds.

Microbiology spectrum·2026
Same journal

ZILA-SRM: a probabilistic framework with zero-inflated latent models for robust strain reconstruction from metagenomes.

Microbiology spectrum·2026
Same journal

Emergence and persistence of ESBL- and carbapenemase-producing <i>Klebsiella pneumoniae</i>-related species in Barcelona wastewater treatment plants.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Clostridium difficile Infection.

Jae Hyun Shin1, Esteban Chaves-Olarte2, Cirle A Warren1

  • 1Department of Medicine, Division of Infectious Disease and International Health, University of Virginia, Charlottesville, VA 22908.

Microbiology Spectrum
|June 24, 2016
PubMed
Summary
This summary is machine-generated.

Clostridium difficile infection (CDI) is a major health threat, causing widespread antibiotic-associated diarrhea. This review examines global CDI epidemiology, including new strains and emerging cases in diverse populations.

More Related Videos

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.3K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K
Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

40.3K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

13.4K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Clostridium difficile is a leading cause of antibiotic-associated diarrhea and a significant health care-associated infection in the US.
  • It is recognized as an urgent public health threat by the CDC due to increasing incidence and emergence of hypervirulent strains.
  • While historically prevalent in the elderly in healthcare settings, CDI is now increasingly reported in children and young adults in community settings.

Purpose of the Study:

  • To describe the global epidemiology of Clostridium difficile infection (CDI).
  • To highlight the circulation of different C. difficile strains worldwide, beyond North America and Europe.
  • To discuss emerging trends, including CDI in pediatric and young adult populations, and novel management strategies.

Main Methods:

  • Review of global epidemiological data on Clostridium difficile infection (CDI).
  • Analysis of C. difficile strain distribution, focusing on regions outside North America and Europe.
  • Discussion of clinical manifestations, host factors, and emerging trends in CDI.

Main Results:

  • Clostridium difficile infection (CDI) is a significant global health concern with high incidence rates.
  • Hypertoxigenic strains have emerged, contributing to increased morbidity and mortality worldwide.
  • CDI is increasingly observed in pediatric and young adult populations in community settings, alongside traditional high-risk groups.

Conclusions:

  • Understanding the global epidemiology of Clostridium difficile infection (CDI) is crucial for effective control and management.
  • Emerging strains and changing demographics necessitate adaptive strategies for intervention.
  • Novel therapeutic approaches, such as fecal microbiota transplantation, show promise for managing recurrent or refractory CDI.